Transcystic management of choledocholithiasis: Outcomes, factors associated with bile duct injury and implications for surgical practice

经胆囊管治疗胆总管结石:疗效、胆管损伤相关因素及其对外科实践的启示

阅读:2

Abstract

BACKGROUNDS/AIMS: Choledocholithiasis with gallbladder in situ presents a complex surgical challenge. The transcystic approach offers a minimally invasive alternative to choledochotomy; however, its adoption remains limited. This study assessed the safety, efficacy, and reproducibility of this method. METHODS: This retrospective study involved 71 patients diagnosed with choledocholithiasis and gallbladder in situ, all of whom underwent transcystic bile duct exploration at a primary care hospital. Demographic, clinical, and intraoperative variables were analyzed to determine predictors of bile duct injury. RESULTS: Transcystic exploration achieved successful completion in 92.9% of cases and a duct clearance rate of 94%. The most common complication was bile duct injury, showing a significant association with previous endoscopic or percutaneous procedures (p = 0.031), increased preoperative leukocyte count (p = 0.050), and advanced age (median 72.7 vs. 60.4 years; p = 0.031). Conversion to choledochotomy elevated the risk of injury, and incomplete duct clearance correlated with higher complication rates. No specific intraoperative techniques or devices exhibited a significant impact on outcomes. Imaging at six months demonstrated no persistent strictures, supporting the likelihood of transient inflammatory changes. CONCLUSIONS: The transcystic approach is a safe, effective, and reproducible first-line intervention for choledocholithiasis with gallbladder in situ. Patient-specific and disease-related factors primarily determine bile duct injury risk, rather than the surgical technique itself. Further prospective randomized studies are needed to confirm these findings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。